Summary
Advances in molecular biology and genetics have provided an abundance of descriptive biological data. Ascribing physiologic roles to these data is an important task to translate this information into improvements in human health. Non-viral transgene delivery of a transgene is a promising approach for defining the physiologic role of a specific protein in vivo. This methodology also has therapeutic potential for the treatment of various diseases. Plasmid DNA injection followed by controlled electric pulses across the injection site (i.e., electroporation or electrotransfer) can dramatically increase transgene expression in skeletal muscle, but in some methods can result in local tissue damage. Muscle damage and subsequent repair processes may confound the measurement of physiological, biochemical, and molecular properties for a given experiment. In addition, it is essential to eliminate damage to existing muscle fibers if such procedures are to be used for the treatment of myopathies and muscle wasting conditions. The measurement of muscle contractile parameters (i.e., function) is an important end-point for assessing the role of ectopically delivered proteins in vivo. As such, methodologies that allow the delivery of a transgene to levels that have a physiological effect and do not compromise muscle function will aid in the characterization of the role of specific proteins in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A. and Cavazzana-Calvo M. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415–419.
Wells D.J. (2006) Viral and non-viral methods for gene transfer into skeletal muscle. Curr. Opin. Drug Discov. Devel. 9, 163–168.
McMahon J.M. and Wells D.J. (2004) Electroporation for gene transfer to skeletal muscles: current status. BioDrugs 18, 155–165.
Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A. and Felgner P.L. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465–1468.
Danko I., Williams P., Herweijer H., Zhang G., Latendresse J.S., Bock I. and Wolff J.A. (1997) High expression of naked plasmid DNA in muscles of young rodents. Hum. Mol. Genet. 6, 1435–1443.
Hartikka J., Bozoukova V., Jones D., Mahajan R., Wloch M.K., Sawdey M., Buchner C., Sukhu L., Barnhart K.M., Abai A.M., Meek J., Shen N. and Manthorpe M. (2000) Sodium phosphate enhances plasmid DNA expression in vivo. Gene Ther. 7, 1171–1182.
Blomberg P., Eskandarpour M., Xia S., Sylven C. and Islam K.B. (2002) Electroporation in combination with a plasmid vector containing SV40 enhancer elements results in increased and persistent gene expression in mouse muscle. Biochem. Biophys. Res. Commun. 298, 505–510.
Andre F.M., Cournil-Henrionnet C., Vernerey D., Opolon P. and Mir L.M. (2006) Variability of naked DNA expression after direct local injection: the influence of the injection speed. Gene Ther. 13, 1619–1627.
Mir L.M., Bureau M.F., Gehl J., Rangara R., Rouy D., Caillaud J.M., Delaere P., Branellec D., Schwartz B. and Scherman D. (1999) High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. U. S. A. 96, 4262–4267.
Niedzinski E.J., Chen Y.J., Olson D.C., Parker E.A., Park H., Udove J.A., Scollay R., McMahon B.M. and Bennett M.J. (2003) Enhanced systemic transgene expression after nonviral salivary gland transfection using a novel endonuclease inhibitor/DNA formulation. Gene Ther. 10, 2133–2138.
Lee M.J., Cho S.S., Jang H.S., Lim Y.S., You J.R., Park J., Suh H., Kim J.A., Park J.S. and Kim D.K. (2002) Optimal salt concentration of vehicle for plasmid DNA enhances gene transfer mediated by electroporation. Exp. Mol. Med. 34, 265–272.
Lefesvre P., Attema J. and van Bekkum D. (2002) A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. B.M.C. Mol. Biol. 3, 12.
Taylor J., Babbs C.F., Alzghoul M.B., Olsen A, Latour M., Pond A.L., and Hannon K. (2004) Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation. B.M.C. Biotechnol. 4, 11.
Schertzer J.D., Plant D.R. and Lynch G.S. (2006) Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol. Ther. 13, 795–803.
McMahon J.M., Signori E., Wells K.E., Fazio V.M. and Wells D.J. (2001) Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage. Gene Ther. 8, 1264–1270.
Schertzer J.D. and Lynch G.S. (2006) Comparative evaluation of IGF-I gene transfer and IGF-I protein administration for enhancing skeletal muscle regeneration after injury. Gene Ther. 13, 1657–1664.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
D., J., and, S., Lynch, G.S. (2008). Plasmid-Based Gene Transfer in Mouse Skeletal Muscle by Electroporation. In: Gene Therapy Protocols. Methods in Molecular Biology™, vol 433. Humana Press. https://doi.org/10.1007/978-1-59745-237-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-59745-237-3_7
Publisher Name: Humana Press
Print ISBN: 978-1-58829-903-1
Online ISBN: 978-1-59745-237-3
eBook Packages: Springer Protocols